syringe driver
Showing 1 - 25 of 743
Healthy Study Participants Trial in London (rozanolixizumab, Placebo)
Completed
- Healthy Study Participants
- rozanolixizumab
- Placebo
-
London, United KingdomUp0106 001
Jan 9, 2023
Generalized Myasthenia Gravis Trial (Rozanolixizumab)
Not yet recruiting
- Generalized Myasthenia Gravis
- (no location specified)
Jan 4, 2023
G- Forces On Retrieved ChildrEn Pilot Study
Unknown status
- Physiological Shock
-
Nottingham, Nottinghamshire, United KingdomNottingham University Hospitals NHS Trust
Mar 24, 2021
Burns Surgery Trial in Paris (active intervention, intervention)
Recruiting
- Burns Surgery
- active intervention
- placebo intervention
-
Paris, FranceSaint Louis Hospital
Aug 8, 2022
Severe Sepsis, Shock, Septic, Acute Kidney Injury Trial in France (56 days of weight-adjusted L-Carnitine treatment, 10 days of
Recruiting
- Severe Sepsis
- +2 more
- 56 days of weight-adjusted L-Carnitine treatment
- 10 days of intravenous placebo (isotonic saline)
-
Caen Cedex 9, France
- +13 more
Mar 8, 2022
Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])
Recruiting
- Pre-fibrotic Myelofibrosis
- Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
-
Taipei, Taiwan, 100, TaiwanNational Taiwan University Hospital
Feb 7, 2023
Real-world Usage of HyQvia in Multiple Myeloma Secondary
Not yet recruiting
- Multiple Myeloma
- Secondary Immunodeficiency (SID)
- No Intervention
- (no location specified)
May 19, 2023
Epidural; Anesthesia, Headache, Analgesia Trial (Labor analgesia)
Not yet recruiting
- Epidural; Anesthesia, Headache
- Analgesia
- Labor analgesia
- (no location specified)
Oct 11, 2023
Anxiety, Dental, Behavior Trial in Jeddah (The buccal infiltration anesthesia with a camouflaged dental syringe (Angelus ™), The
Not yet recruiting
- Anxiety, Dental
- Behavior
- The buccal infiltration anesthesia with a camouflaged dental syringe (Angelus ™)
- The buccal infiltration anesthesia with a conventional dental syringe
-
Jeddah, Saudi ArabiaKing AbdulAziz University
Oct 31, 2023
Chorioretinal Vascular Disease Trial (Patients will receive 1 IVT injection of AVT06 PFS depending on their chorioretinal
Not yet recruiting
- Chorioretinal Vascular Disease
- Patients will receive 1 IVT injection of AVT06 PFS depending on their chorioretinal vascular disease schedule
- (no location specified)
Aug 11, 2023
Paroxysmal Atrial Fibrillation Trial in Japan (M201-A Injection, Placebo)
Unknown status
- Paroxysmal Atrial Fibrillation
- M201-A Injection
- Placebo
-
Koga-City, Ibaraki, Japan
- +4 more
Oct 23, 2020
Bioequivalence Trial in Tempe, Lincoln (efgartigimod PH20 SC as a prefilled syringe presentation, efgartigimod PH20 SC as a vial
Recruiting
- Bioequivalence
- efgartigimod PH20 SC as a prefilled syringe presentation
- efgartigimod PH20 SC as a vial + syringe presentation
-
Tempe, Arizona
- +1 more
Apr 5, 2023
Loss-of-resistance Syringe Technique in Determining Endotracheal
Completed
- Endotracheal Tube Cuff Pressure
- +3 more
- Endotracheal tube cuff inflation with the loss of resistance syringe method
-
Ankara, TurkeyAnkara City Hospital
Apr 12, 2023
Premature Birth Trial in Avignon, Limoges (enteral feeding with pushed syringe by the parents)
Recruiting
- Premature Birth
- enteral feeding with pushed syringe by the parents
-
Avignon, France
- +1 more
Jul 26, 2022
Haemophilia A Trial in Berlin (NNC0365-3769 (Mim8))
Recruiting
- Haemophilia A
- NNC0365-3769 (Mim8)
-
Berlin, GermanyNovo Nordisk Investigational Site
Jan 24, 2023
NSCLC Stage II, Bevacizumab, Immunotherapy Trial in Guangzhou (Serplulimab combined with bevacizumab and first-line chemo)
Not yet recruiting
- Non-small Cell Lung Cancer Stage II
- +3 more
- Serplulimab combined with bevacizumab and first-line chemotherapy
-
Guangzhou, Guangdong, ChinaLikun Chen
Apr 10, 2023
Hepatitis C, Opioid Use Disorder, IV Drug Usage Trial in Keene, Brattleboro (Mobile Tele-HCV Care, Enhanced Usual Care)
Recruiting
- Hepatitis C
- +2 more
- Mobile Tele-HCV Care
- Enhanced Usual Care
-
Keene, New Hampshire
- +1 more
Jul 18, 2022
Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)
Not yet recruiting
- Diabetic Macular Edema (DME)
- Neovascular Age-Related Macular Degeneration (nAMD)
- aflibercept 8 mg PFS
- (no location specified)
Aug 3, 2023
Atrial Fibrillation Driver Study
Not yet recruiting
- Atrial Fibrillation
- Fibrosis Myocardial
- Tissue excision as part of routine clinical care
- (no location specified)
Feb 14, 2023
Catheterization, Central Venous, Equipment Design, Patient Safety Trial in Taipei (EpiFaith CV, Conventional)
Not yet recruiting
- Catheterization, Central Venous
- +4 more
- EpiFaith CV
- Conventional
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 20, 2023
Achondroplasia Trial in Dallas (BMN 111 administration via Injector Pen, BMN 111 administration via vial and syringe)
Recruiting
- Achondroplasia
- BMN 111 administration via Injector Pen
- BMN 111 administration via vial and syringe
-
Dallas, TexasLabcorp
Apr 2, 2023
COPD Exacerbation, COPD Exacerbation Acute Trial (Titrated Oxygen, Standard Oxygen)
Not yet recruiting
- COPD Exacerbation
- COPD Exacerbation Acute
- Titrated Oxygen
- Standard Oxygen
- (no location specified)
Feb 2, 2023
Asthma Trial in Japan
Active, not recruiting
- Asthma
-
Aichi, Japan
- +34 more
Jan 11, 2023